Handelsavisen
prelaunch
Companies Healthcare 7091.T
70
7091.T Tokyo Stock Exchange Healthcare Facilities & Services

Living Platform Ltd

¥1 170,00
Open in Charts → Attach watcher ⌖
JPY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
5,2B JPY
P/E
11,0x
EV / Rev
0,5x
Div yield
0,00 %
Op margin
1,1 %
ROE
6,3 %
Net margin
2,4 %
Debt / equity
3,60
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Living Platform Ltd provides healthcare services and equipment, primarily generating revenue through its operations in the healthcare facilities and services sector.

Business. Living Platform Ltd (7091.T) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
ActivityBiotechnology
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
11,0x
P/E
Analysts
not yet wired
Ownership
not yet wired
Profitability
6,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 7091.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 7091.T. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Living Platform Ltd (7091.T) is a healthcare services and equipment company primarily engaged in biotechnology activities within the healthcare facilities and services industry. The firm is headquartered in Japan and is listed on the Tokyo Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryHealthcare Facilities & Services
    ActivityBiotechnology
    AI synthesis
    GENERATED

    Living Platform Ltd has a liquidity position that is characterized by a current ratio of 1.08, indicating that the company has just enough current assets to cover its current liabilities. The company's price-to-book ratio is 3.17, and its price-to-tangible-book ratio is also 3.17, suggesting that the market is valuing the company's equity at a premium relative to its book value. The company's debt-to-equity ratio is 3.6, which is relatively high and indicates a significant reliance on debt financing.

    In terms of profitability, Living Platform Ltd has a return on equity of 6.3%, which is a measure of how effectively the company is using shareholders' equity to generate profits. The return on assets is 0.94%, which is relatively low and suggests that the company is not efficiently using its assets to generate earnings. These metrics are compared against the industry's preferred metrics, and the company's performance appears to be below the median for its industry.

    The company's revenue is concentrated in a single segment, as there are no disclosed segments beyond the overall healthcare facilities and services operations. Geographically, the company's exposure is primarily within Japan, as the financial data is reported in Japanese Yen and there is no indication of significant international operations.

    Looking at the growth trajectory, the company's revenue for the latest period is reported at 4,369,434,000 JPY. The analyst estimates for the last actual revenue were 19,204,570,000 JPY, which suggests a significant discrepancy between the reported revenue and the analyst estimates. This discrepancy may indicate either a change in the company's operations or a potential issue with the accuracy of the financial reporting.

    The risk assessment for Living Platform Ltd indicates a medium level of liquidity risk, with a key flag noting that the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, which suggests that the company is not expected to issue additional shares that could dilute existing shareholders' equity in the near term. The company's capital structure, with a high debt-to-equity ratio, may also contribute to credit risk, as the company's ability to meet its debt obligations could be affected by changes in interest rates or economic conditions.

    Recent events related to Living Platform Ltd include the latest financial reporting, which shows a net income of 104,666,000 JPY. The company's operating cash flow is positive at 1,509,635,000 JPY, which is a positive sign for its ability to generate cash from operations. However, the capital expenditure is reported as a negative value of -631,301,000 JPY, which may indicate that the company is investing in new projects or assets. These recent financial activities suggest that the company is actively managing its operations and investments.

    Key takeaways
    • Living Platform Ltd has a high debt-to-equity ratio of 3.6, indicating a significant reliance on debt financing.
    • The company's return on equity is 6.3%, which is a measure of how effectively the company is using shareholders' equity to generate profits.
    • The company's liquidity position is characterized by a current ratio of 1.08, indicating that the company has just enough current assets to cover its current liabilities.
    • The company's price-to-book ratio is 3.17, suggesting that the market is valuing the company's equity at a premium relative to its book value.
    • The company's net income is 104,666,000 JPY, and its operating cash flow is positive at 1,509,635,000 JPY, indicating a positive cash flow from operations.
    • The company's capital expenditure is reported as a negative value of -631,301,000 JPY, which may indicate that the company is investing in new projects or assets.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Revenue grew 20.4% annually over four years, demonstrating strong top-line expansion momentum for the company.

    Net income surged 93.1% year-over-year in fiscal 2025, indicating a significant acceleration in profitability.

    Free cash flow turned positive in fiscal 2025, marking a critical shift from previous years of negative cash generation.

    Cash conversion ratio of 14.42 is best-in-class compared to the cohort median of 1.36, highlighting operational strength.

    BEAR CASE · 3

    Debt-to-equity ratio of 3.6 is significantly higher than the cohort median of 0.32, indicating excessive financial leverage.

    The company faces high credit risk, suggesting potential difficulties in meeting financial obligations or securing favorable financing.

    Medium liquidity risk flags potential challenges in meeting short-term financial obligations without significant asset liquidation.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-02-13
    Q4 2025 · Quarter highlights

    Revenue ¥5.63B, +14,5% YoY; Operating income +37,9% YoY.

    Revenue¥5.63B+14,5 % YoY
    Operating income¥151.5M+37,9 % YoY
    Net income¥96.5M+69,7 % YoY
    Free cash flow
    EPS
    Operating cash flow
    Financials
    Income statement
    Revenue¥5.63B
    Gross profit¥618.2M
    Operating income¥151.5M
    Net income¥96.5M
    Margins
    Gross margin11.0%
    Operating margin2.7%
    Net margin1.7%
    FCF margin
    Balance sheet
    Total assets¥13.06B
    Total liabilities¥10.71B
    Total equity¥2.35B
    Cash & equivalents¥1.78B
    Long-term debt¥6.45B
    P&L flow · revenue → net income
    Revenue ¥5.63BOperating costs ¥5.47BTax ¥55.0MNet income ¥96.5M
    Highlights
    • Revenue ¥5.63B, +14,5% YoY
    • Operating income +37,9% YoY
    • Net income +69,7% YoY
    • Net margin 1.7%

    Valuation TTM

    Market price
    ¥1 170,00
    Market cap
    ¥5.27B
    Enterprise value
    ¥10.13B
    P/E
    11.0x
    Non-GAAP P/E
    EV / Revenue
    0.5x
    EV / Op income
    18.5x
    EV / OCF
    6.7x
    P / B
    3.2x
    P / Tangible book
    3.2x
    Tangible book
    ¥1.66B
    Net cash
    -¥4.85B
    Current ratio
    1.1
    Debt / equity
    3.6
    ROA
    0.9%
    ROE
    6.3%
    Cash conversion
    1442.0%
    CapEx / revenue
    -14.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,1 %Below median
    Net Margin2,4 %Below median
    ROE6,3 %Above median
    Capex / Rev-14,4 %Below median
    D/E3,60Bottom quartile
    Cash Conv14,42Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • Living Platform Ltd Market data — financials · 2026-05-27
    • Living Platform Ltd Market data — analyst estimates · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    7091.TCanonical
    Tokyo Stock Exchange · JPY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-02-13 12:00 UTCEARNINGSQuarterly results — Q4 2025 Revenue JPY 5.63B · Net JPY 96.5M
    2025-11-14 10:41 UTCEARNINGSQuarterly results — Q3 2025 Revenue JPY 5.43B · Net JPY 89.6M
    2025-08-14 09:14 UTCEARNINGSQuarterly results — Q2 2025 Revenue JPY 5.35B · Net JPY 89.3M
    2025-05-15 12:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue JPY 5.01B · Net JPY 206.2M
    2025-05-15 12:00 UTCEARNINGSAnnual results — FY 2025 Revenue JPY 19.20B · Net JPY 365.6M
    2025-02-14 12:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue JPY 4.91B · Net JPY 56.9M
    2024-11-14 12:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue JPY 4.72B · Net JPY 55.5M
    2024-08-14 12:30 UTCEARNINGSQuarterly results — Q2 2024 Revenue JPY 4.56B · Net JPY 47.0M
    2024-05-15 13:00 UTCEARNINGSQuarterly results — Q1 2024 Revenue JPY 4.37B · Net JPY 104.7M
    2024-05-15 13:00 UTCEARNINGSAnnual results — FY 2024 Revenue JPY 16.66B · Net JPY 189.3M
    2023-05-15 13:00 UTCEARNINGSAnnual results — FY 2023 Revenue JPY 13.69B · Net JPY 91.7M
    2022-05-13 12:20 UTCEARNINGSAnnual results — FY 2022 Revenue JPY 11.63B · Net JPY 408.0M
    2021-05-14 11:40 UTCEARNINGSAnnual results — FY 2021 Revenue JPY 9.13B · Net JPY 56.9M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage